MAINZ BIOMED NV (QUCY) Stock Income Statement
NASDAQ:QUCY • NL0015000LC2
Current stock price
0.5398 USD
+0.03 (+6.34%)
At close:
0.505 USD
-0.03 (-6.45%)
Pre-Market:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 537.10K | 894.00K | 895.50K | 530.00K | 580.00K | |||
| Cost Of Goods | 147.30K | 319.10K | 385.80K | 350.00K | 400.00K | |||
| Gross Profit | 389.80K | 574.90K | 509.70K | 180.00K | 180.00K | |||
| Operating Expenses | 13.89M | 18.99M | 27.15M | 26.69M | 9.90M | |||
| Research and Development | 4.39M | 5.20M | 9.07M | 3.55M | 440.00K | |||
| Selling, General, and Administrative Expenses | 8.88M | 12.77M | 17.22M | 22.88M | 9.40M | |||
| Operating Income | -13.50M | -18.42M | -26.64M | -26.51M | -9.72M | |||
| Interest Income/Expense | -308.30K | -1.07M | -809.60K | -210.00K | -200.00K | |||
| Other Income/Expense | 399.90K | -1.92M | 1.10M | 330.00K | 250.00K | |||
| Non Recurring Items | -2.64M | -248.80K | 55.30K | 0.00 | -2.02M | |||
| Income Before Taxes | -16.21M | -21.65M | -26.30M | -26.39M | -11.69M | |||
| Net Income | -16.21M | -21.65M | -26.30M | -26.39M | -11.69M | |||
| EBITDA | -12.88M | -17.40M | -25.78M | -26.13M | -9.65M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.70 | -22.36 | -64.76 | -74.56 | -33.49 | |||
| Non GAAP EPS | N/A | N/A | -48.05 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 72.57% | 64.31% | 56.92% | 33.96% | 31.03% | |||
| Profit Margin | -3018.19% | -2421.78% | -2936.43% | -4979.25% | -2015.52% | |||
| Operating Profit Margin | -2513.27% | -2060.20% | -2975.40% | -5001.89% | -1675.86% | |||
All data in USD